The discovery and functional validation of recurrent gene fusions of 5 Ets factor genes (ETV1, ETV4, ETV5, ERG, Fli1) in prostate cancer highlights the relevance of Ets transcription factors as oncogenes in prostate cancer [2-4]. This evidence concerns the gene ETV4 and prostate carcinoma.